Press Release

Theranos Founder and CEO Elizabeth Holmes to Present Research on Theranos’ Proprietary Technologies at the 68th AACC Annual Scientific Meeting

WASHINGTON – AACC is pleased to announce that Theranos founder and CEO Elizabeth Holmes will speak in a special session at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia. For the first time, Holmes will present data at a scientific conference that describes Theranos’ technologies, including small sample volume testing and finger-stick collection.

After Theranos launched its retail testing service in 2013, it quickly gained national prominence with its promise of revolutionizing the way lab testing works in the United States. The company asserted that its proprietary technologies could perform tests on a capsule-sized blood sample collected from patients via finger-stick. Using these tiny samples, the company promised to improve access and provide results more quickly than traditional lab companies, while charging less.

Holmes will present on Theranos’ technologies on August 1 at the 68th AACC Annual Scientific Meeting, the largest and most recognized international forum for presenting vital science and groundbreaking advances in laboratory medicine. Attendees of the meeting are experts in the field, with the knowledge and experience needed to assess Theranos’ data. After her presentation, Holmes will answer questions from these experts to further clarify the science, accuracy, and reliability of Theranos’ technologies, as well as its impact on patient care and safety.

“There is no better place to present Theranos’ technology than at the AACC Annual Scientific Meeting, where leaders in laboratory medicine can evaluate Ms. Holmes’ data and research,” said AACC CEO Janet B. Kreizman. “AACC members have been asking for this information, and we are thrilled that Ms. Holmes is presenting the science behind the technology for the first time at AACC, the premier scientific forum for laboratory medicine.”

Session Information

AACC Annual Scientific Meeting registration is free for members of the media. Reporters can register online here:

Monday, August 1
4:30–6 p.m.
Grand Ballroom
Pennsylvania Convention Center

About the 68th AACC Annual Scientific Meeting & Clinical Lab Expo

The AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about exciting science from July 31–August 4. Plenary sessions feature the latest research on the use of and testing for cannabis, combatting premature death due to preventable causes such as tobacco and alcohol, the development of an “intelligent” surgical knife, programmable bio-nano-chips, and the epigenetic causes of disease.

At the AACC Clinical Lab Expo, more than 750 exhibitors will fill the show floor of Philadelphia’s Pennsylvania Convention Center, with displays of the latest diagnostic technology, including but not limited to mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation.

About AACC

Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit





Media Contacts

Christine DeLong
Association for Diagnostics & Laboratory Medicine
Associate Director, Communications & PR
(p) 202.835.8722
[email protected]

Molly Polen
Association for Diagnostics & Laboratory Medicine
Senior Director, Communications & PR
(p) 202.420.7612
(c) 703.598.0472
[email protected]